2025-11-14T17:53:42-06:00 2024-12-31 390859910 BAKER TILLY ADVISORY GROUP LP 101 SECOND STREET SUITE 900 SAN FRANCISCO CA 94105 990 2024-01-01 452035413 RICE INSTITUTE INC RICE 2022945070 472 OLD COLCHESTER ROAD AMSTON CT 06231 PAYAL HATHI MANAGING DIRECTOR 2022945070 2025-11-14 1 0 MICHAEL LUMSDEN P01262236 4159561500 2025-11-14 2024 2025-03-06 01:10:19Z DEAN SPEARS 472 OLD COLCHESTER ROAD AMSTON CT 06231 163937 0 X WWW.RICEINSTITUTE.ORG X 2011 CT RESEARCH AND POLICY ADVOCACY FOR HEALTH AND WELL-BEING IN INDIA. 5 5 0 10 0 0 2452967 86273 0 0 6692 77664 25 0 2459684 163937 0 0 0 0 20836 1261 0 0 0 457729 736689 478565 737950 1981119 -574013 2138011 1566893 0 0 2138011 1566893 X R.I.C.E. IS A RESEARCH INSTITUTE FOR COMPASSIONATE ECONOMICS. WE ARE A NON-PROFIT RESEARCH ORGANIZATION FOCUSED ON HEALTH AND WELL-BEING IN INDIA. OUR CORE FOCUS IS ON CHILDREN IN RURAL NORTH INDIA. OUR RESEARCH STUDIES HEALTH CARE AT THE START OF LIFE, SANITATION, AIR POLLUTION, MATERNAL HEALTH, NEWBORN HEALTH, SOCIAL INEQUALITY, AND OTHER DIMENSIONS OF POPULATION-LEVEL SOCIAL WELLBEING. 0 0 731912 0 0 IN 2024 R.I.C.E. RESEARCHERS STUDIED ALTERNATIVE MEASUREMENTS OF MATERNAL MORTALITY, CONDUCTED RESEARCH ON GLOBAL PATTERNS OF STILLBIRTH, INVESTIGATED MEASUREMENT OF OPEN DEFECATION IN SAMPLE SURVEYS, STUDIED GROUP PREDICTORS OF LIFE EXPECTANCY, AND CONDUCTED RESEARCH ON THE CAUSES AND CONSEQUENCES OF GLOBAL BIRTH RATES; AND ALSO CONTRACTED WITH POPULATION HEALTH INSIGHTS (PHI) RELATED TO OUR PARTNERSHIP WITH MSDASMC BAHRAICH ON NEONATAL HEALTH. 731912 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 5 5 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 0 0 0 0 0 CT X PAYAL HATHI 2022945070 472 OLD COLCHESTER ROAD AMSTON CT 06231 X LOUIS BOORSTIN BOARD MEMBER 1.00 X 0 0 0 JOSEPHINE DUH BOARD MEMBER 1.00 X 0 0 0 MIKE GERUSO BOARD MEMBER 1.00 X 0 0 0 AVINASH KISHORE BOARD MEMBER 1.00 X 0 0 0 JOHN PAPP BOARD MEMBER 1.00 X 0 0 0 DEAN SPEARS CO-EXECUTIVE DIRECTOR 10.00 X 0 0 0 DIANE COFFEY CO-EXECUTIVE DIRECTOR 10.00 X 0 0 0 PAYAL HATHI MANAGING DIRECTOR / RESEARCH FELLOW 10.00 X 0 0 0 SANGITA VYAS MANAGING DIRECTOR / RESEARCH FELLOW 10.00 X 0 0 0 AASHISH GUPTA RESEARCH FELLOW 1.00 X 0 0 0 0 0 0 0 0 0 0 POPULATION HEALTH INSIGHTS F-3055 RAJAJIPURAM LUCKNOW IN 226017 CONTRACT CONSULTANCY 724470 1 86273 86273 77664 77664 163937 0 0 77664 X 922 922 339 339 4500 4500 728308 728308 504 504 1594 660 934 1683 1683 LICENSES & RENEWAL 100 100 737950 731912 6038 0 629414 197738 1508597 1369155 2138011 1566893 0 0 X 2138011 1566893 2138011 1566893 2138011 1566893 -574013 2895 0 X 0 0 0 X 26969 12774 170285 2452967 86273 2749268 26969 12774 170285 2452967 86273 2749268 68327 2680941 6692 77664 84356 25 25 2833649 0.94610 0.87970 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: REVERSED CHARGES - 2023 AMOUNT: $ 25. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED SOUTH ASIA 0 2 RESEARCH PROGRAM SERVICES CONTRACT CONSULTANCY 729970 0 2 0 0 0 2 729970 0 729970 0 0 0 0 0 0 PART I, LINE 3: THE ORGANIZATION IS UTILIZING THE CASH METHOD TO ACCOUNT FOR EXPENDITURES ON SCHEDULE F, PART I. FORM 990, PART VI, SECTION A, LINE 8B THE ORGANIZATION DOES NOT HAVE A COMMITTEE OR COMMITTEES WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY AN INDEPENDENT TAX ACCOUNTANT IN CONJUNCTION WITH MEMBERS OF THE ORGANIZATION'S MANAGEMENT TEAM. THE DRAFT FORM 990 IS THEN REVIEWED BY MANAGEMENT; ADJUSTMENTS ARE MADE, AS NECESSARY. PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE, A COMPLETE COPY OF THE FORM 990 IS MADE AVAILABLE TO ALL MEMBERS OF THE GOVERNING BODY PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE BOARD OF DIRECTORS, WHO WILL CONSIDER THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE SHALL LEAVE THE BOARD OF DIRECTORS MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE GOVERNING BOARD OR COMMITTEE MEETING, BUT AFTER THE PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. THE BOARD OF DIRECTORS, IF APPROPRIATE, MAY APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER EXERCISING DUE DILIGENCE, THE INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS SHALL DETERMINE WHETHER THE CORPORATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE UNDER CIRCUMSTANCES NOT PRODUCING A CONFLICT OF INTEREST, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE CORPORATION'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION, IT SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION DID NOT COMPENSATE ANY OFFICERS OR KEY EMPLOYEES DURING 2024; ACCORDINGLY, FORM 990, PART VI, SECTION B, LINES 15A AND 15B HAVE BEEN ANSWERED "NO". FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONTRACT RESEARCH SERVICES: PROGRAM SERVICE EXPENSES 728,308. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 728,308.